Status:
COMPLETED
Modification of the Local Abnormal Ventricular Activity Only
Lead Sponsor:
University of Kiel
Collaborating Sponsors:
Krankenhaus Landshut Achdorf
Conditions:
Ventricular Tachycardia
Eligibility:
All Genders
18+ years
Brief Summary
Local abnormal ventricular activity (LAVA) is composed of high-frequency, mainly low voltage signals that represent near-field signals from slow-conducting tissue and thus potential VT isthmuses. The ...
Detailed Description
As of 2019 we started LAVA modification only in a subset of patients with therapy refractory ventricular tachycardia. The cohort icludes 55% patient with ischemic cardiomyopathy and 45% with dilated c...
Eligibility Criteria
Inclusion
- therapy refractory ventricular arrhythmia
Exclusion
- none
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT05331716
Start Date
January 1 2019
End Date
December 31 2021
Last Update
October 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Krankenhaus Landshut Achdorf
Landshut, Bavaria, Germany, 84036